Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuangxiong Aerosol for Coronary Microvascular Disease
NCT06901570Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Apr 2025
- Primary completion
- Jul 2028
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of kuanxiong aerosol in coronary microvascular disease (CMD), sponsored by China-Japan Friendship Hospital. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
kuanxiong aerosol
03
Conditions
coronary microvascular disease (CMD)
Beyond the preview
Go deeper on NCT06901570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901570.